Biotech · Public company · Boston, MA, US
Bambusa Therapeutics, Inc.
Ticker BBTX · SEC CIK 0002044950
Track this companyFree. Adds Bambusa Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- BBT001Phase 1 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- BBT002Phase 1 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)PHASE1 · RECRUITING · started May 8, 2025ClinicalTrials.gov NCT06944925 · fetched Nov 12, 2026
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)PHASE1 · RECRUITING · started Feb 27, 2025ClinicalTrials.gov NCT06808477 · fetched Nov 12, 2026